Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3 - International Nuclear Solutions

3 Jul 2007 14:25

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION \* TName of person dealing (Note 1) TRAFALGAR ASSET MANAGERS LTD---------------------------------------------------------------------------------------------------------Company dealt in International Nuclear Solutions - INS LN---------------------------------------------------------------------------------------------------------Class of relevant security to which the Ordinary dealings being disclosed relate (Note 2)---------------------------------------------------------------------------------------------------------Date of dealing 02 July 2007---------------------------------------------------------------------------------------------------------\* T 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) \* T Long Short-------------------------------------------------------------------------------------------------------- Number (%) Number (%)--------------------------------------------------------------------------------------------------------(1) Relevant securities 4,881,964 7.83%--------------------------------------------------------------------------------------------------------(2) Derivatives (other than options) 2,781,407 4.46%--------------------------------------------------------------------------------------------------------(3) Options and agreements to purchase/sell--------------------------------------------------------------------------------------------------------Total 7,663,371 12.29%--------------------------------------------------------------------------------------------------------\* T (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) \* T Class of relevant security: Long Short-------------------------------------------------------------------------------------------------------- Number (%) Number (%)--------------------------------------------------------------------------------------------------------(1) Relevant securities--------------------------------------------------------------------------------------------------------(2) Derivatives (other than options)--------------------------------------------------------------------------------------------------------(3) Options and agreements to purchase/sell--------------------------------------------------------------------------------------------------------Total--------------------------------------------------------------------------------------------------------\* T (c) Rights to subscribe (Note 3) \* TClass of relevant security: Details---------------------------------------------------------------------------------------------------------\* T 3. DEALINGS (Note 4) (a) Purchases and sales \* TPurchase/sale Number of securities Price per unit (Note 5)---------------------------------------------------------------------------------------------------------\* T (b) Derivatives transactions (other than options) \* TProduct name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)e.g. CFD--------------------------------------------------------------------------------------------------------CFD Long 100,000 63.3133p--------------------------------------------------------------------------------------------------------\* T (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying \* TProduct name, Writing, Number of Exercise Type, e.g. Expiry Option moneye.g. call option selling, securities to price American, date paid/received purchasing, which the option European per unit (Note varying etc. relates (Note 7) etc. 5)-------------------------------------------------------------------------------------------------------\* T (ii) Exercising \* TProduct name, e.g. call option Number of securities Exercise price per unit (Note 5)---------------------------------------------------------------------------------------------------------\* T (d) Other dealings (including new securities) (Note 4) \* TNature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)---------------------------------------------------------------------------------------------------------\* T 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives \* TFull details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.---------------------------------------------------------------------------------------------------------\* T Is a Supplemental Form 8 attached? (Note 9) NO \* TDate of disclosure 03 July 2007---------------------------------------------------------------------------------------------------------Contact name Marie Lawlor---------------------------------------------------------------------------------------------------------Telephone number 020 7534 6018---------------------------------------------------------------------------------------------------------If a connected EFM, name of offeree/offeror with which connected---------------------------------------------------------------------------------------------------------If a connected EFM, state nature of connection (Note 10)---------------------------------------------------------------------------------------------------------\* T Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk Copyright Business Wire 2007
Date   Source Headline
15th May 20237:00 amRNSTransfer of ToxHub Platform and launch of Centrus®
11th May 20233:26 pmRNSHolding(s) in Company
11th May 20237:00 amRNSUS Government Contract Award
4th May 20235:07 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSNotice of Results and Investor Presentation
2nd May 20234:13 pmRNSExercise of Options, Issue of Equity & TVR
14th Apr 20234:38 pmRNSHolding(s) in Company
13th Mar 20237:30 amRNSNo Exposure to Silicon Valley Bank
31st Jan 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
5th Jan 20237:00 amRNSExercise of Options, Director/PDMR Dealing & TVR
22nd Dec 20227:00 amRNSContract Extension with Leading CRO
30th Nov 20225:48 pmRNSHolding(s) in Company
12th Oct 20227:00 amRNSExercise of Options, Issue of Equity and TVR
27th Sep 20227:01 amRNSHalf-year Report
27th Sep 20227:00 amRNSSettlement of Historical Licence Dispute
13th Sep 20227:00 amRNSNotice of Results and Investor Presentation
9th Sep 20223:49 pmRNSHolding(s) in Company
2nd Sep 20227:00 amRNS$12m five-year agreement with Leading CRO
4th Aug 20227:00 amRNSHalf Year Trading Update
29th Jun 20225:03 pmRNSHolding(s) in Company
9th Jun 20224:01 pmRNSResult of AGM
20th May 20224:31 pmRNSHolding(s) in Company
17th May 20227:00 amRNSNotice of AGM & Posting of Annual Report
3rd May 202212:00 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSEuropean Medicines Agency Research Grant
26th Apr 20224:40 pmRNSSecond Price Monitoring Extn
26th Apr 20224:35 pmRNSPrice Monitoring Extension
26th Apr 202210:15 amRNSEarn Outs and Deferred Payments
26th Apr 20229:54 amRNSFinal Results
26th Apr 20227:00 amRNSAnnouncement re: full year results
20th Apr 20229:05 amRNSNotice of Results & Investor Presentation
15th Mar 20221:49 pmRNSGrant of PDMR Options
14th Mar 20225:29 pmRNSExercise of Options, Issue of Equity and TVR
14th Mar 202211:22 amRNSHolding(s) in Company
22nd Feb 202210:15 amRNSHolding(s) in Company
4th Feb 20228:08 amRNSDirector/PDMR Shareholding
26th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSAppointment of Joint Broker
21st Dec 20217:00 amRNSH2 China Market Update
13th Dec 20214:55 pmRNSHolding(s) in Company
22nd Nov 20212:33 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSNew In Silico Software Release
11th Oct 20213:15 pmRNSDirector/PDMR Shareholding
29th Sep 202110:34 amRNSHolding(s) in Company
29th Sep 20217:00 amRNSDirectorate Change
28th Sep 20217:00 amRNSGrant of PDMR Options
27th Sep 20217:00 amRNSHalf-year Report
14th Sep 20217:00 amRNSNotice of Results and Investor Presentation
14th Sep 20217:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.